These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 15910884)
1. A second N-acylethanolamine hydrolase in mammalian tissues. Ueda N; Tsuboi K; Lambert DM Neuropharmacology; 2005 Jun; 48(8):1079-85. PubMed ID: 15910884 [TBL] [Abstract][Full Text] [Related]
2. N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase. Tsuboi K; Hilligsmann C; Vandevoorde S; Lambert DM; Ueda N Biochem J; 2004 Apr; 379(Pt 1):99-106. PubMed ID: 14686878 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase. Saturnino C; Petrosino S; Ligresti A; Palladino C; De Martino G; Bisogno T; Di Marzo V Bioorg Med Chem Lett; 2010 Feb; 20(3):1210-3. PubMed ID: 20022504 [TBL] [Abstract][Full Text] [Related]
4. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384 [TBL] [Abstract][Full Text] [Related]
6. Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide. Day TA; Rakhshan F; Deutsch DG; Barker EL Mol Pharmacol; 2001 Jun; 59(6):1369-75. PubMed ID: 11353795 [TBL] [Abstract][Full Text] [Related]
7. An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors. Ueda N; Yamanaka K; Terasawa Y; Yamamoto S FEBS Lett; 1999 Jul; 454(3):267-70. PubMed ID: 10431820 [TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. Ueda N; Yamanaka K; Yamamoto S J Biol Chem; 2001 Sep; 276(38):35552-7. PubMed ID: 11463796 [TBL] [Abstract][Full Text] [Related]
10. Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolase. Fowler CJ; Börjesson M; Tiger G Br J Pharmacol; 2000 Oct; 131(3):498-504. PubMed ID: 11015300 [TBL] [Abstract][Full Text] [Related]
11. Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells. Wang J; Zhao LY; Uyama T; Tsuboi K; Wu XX; Kakehi Y; Ueda N J Biochem; 2008 Nov; 144(5):685-90. PubMed ID: 18806270 [TBL] [Abstract][Full Text] [Related]
12. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies. Mor M; Rivara S; Lodola A; Plazzi PV; Tarzia G; Duranti A; Tontini A; Piersanti G; Kathuria S; Piomelli D J Med Chem; 2004 Oct; 47(21):4998-5008. PubMed ID: 15456244 [TBL] [Abstract][Full Text] [Related]
13. High-throughput screening for the discovery of inhibitors of fatty acid amide hydrolase using a microsome-based fluorescent assay. Wang Y; Ramirez F; Krishnamurthy G; Gilbert A; Kadakia N; Xu J; Kalgaonkar G; Ramarao MK; Edris W; Rogers KE; Jones PG J Biomol Screen; 2006 Aug; 11(5):519-27. PubMed ID: 16760367 [TBL] [Abstract][Full Text] [Related]
14. A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison. Labar G; Vliet FV; Wouters J; Lambert DM Amino Acids; 2008 Jan; 34(1):127-33. PubMed ID: 17476568 [TBL] [Abstract][Full Text] [Related]
15. A fluorescence-based assay for fatty acid amide hydrolase compatible with high-throughput screening. Ramarao MK; Murphy EA; Shen MW; Wang Y; Bushell KN; Huang N; Pan N; Williams C; Clark JD Anal Biochem; 2005 Aug; 343(1):143-51. PubMed ID: 16018870 [TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. Tsuboi K; Sun YX; Okamoto Y; Araki N; Tonai T; Ueda N J Biol Chem; 2005 Mar; 280(12):11082-92. PubMed ID: 15655246 [TBL] [Abstract][Full Text] [Related]
17. A spectrophotometric assay for fatty acid amide hydrolase suitable for high-throughput screening. De Bank PA; Kendall DA; Alexander SP Biochem Pharmacol; 2005 Apr; 69(8):1187-93. PubMed ID: 15794939 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors. Myllymäki MJ; Saario SM; Kataja AO; Castillo-Melendez JA; Nevalainen T; Juvonen RO; Järvinen T; Koskinen AM J Med Chem; 2007 Aug; 50(17):4236-42. PubMed ID: 17665899 [TBL] [Abstract][Full Text] [Related]
20. Fatty acid amide hydrolase: from characterization to therapeutics. Labar G; Michaux C Chem Biodivers; 2007 Aug; 4(8):1882-902. PubMed ID: 17712824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]